BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 35011273)

  • 1. Copper(II) Phenanthroline-Based Complexes as Potential AntiCancer Drugs: A Walkthrough on the Mechanisms of Action.
    Masuri S; Vaňhara P; Cabiddu MG; Moráň L; Havel J; Cadoni E; Pivetta T
    Molecules; 2021 Dec; 27(1):. PubMed ID: 35011273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Study of Antioxidant and Pro-Oxidant Properties of Homoleptic and Heteroleptic Copper Complexes with Amino Acids, Dipeptides and 1,10-Phenanthroline: The Quest for Antitumor Compounds.
    Veiga N; Alvarez N; Castellano EE; Ellena J; Facchin G; Torre MH
    Molecules; 2021 Oct; 26(21):. PubMed ID: 34770929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, characterization, and antitumor activity of unusual pseudo five coordinate gold(III) complexes: distinct cytotoxic mechanism or expensive ligand delivery systems?
    Olsen PM; Ruiz C; Lussier D; Le BK; Angel N; Smith M; Hwang CB; Khatib R; Jenkins J; Adams K; Getcher J; Tham F; Chen ZG; Wilson EH; Eichler JF
    J Inorg Biochem; 2014 Dec; 141():121-131. PubMed ID: 25243390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel copper(II) complexes as new promising antitumour agents. A crystal structure of [Cu(1,10-phenanthroline-5,6-dione)2(OH2)(OClO3)](ClO4).
    Pivetta T; Trudu F; Valletta E; Isaia F; Castellano C; Demartin F; Tuveri R; Vascellari S; Pani A
    J Inorg Biochem; 2014 Dec; 141():103-113. PubMed ID: 25238635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platinum(II) and Copper(II) complexes of asymmetric halogen-substituted [NN'O] ligands: Synthesis, characterization, structural investigations and antiproliferative activity.
    Amiri Rudbari H; Saadati A; Aryaeifar M; Blacque O; Cuevas-Vicario JV; Cabral R; Raposo LR; Fernandes AR
    Bioorg Chem; 2022 Feb; 119():105556. PubMed ID: 34959175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenanthroline and Schiff Base associated Cu(II)-coordinated compounds containing N, O as donor atoms for potent anticancer activity.
    Richa ; Kumar V; Kataria R
    J Inorg Biochem; 2024 Feb; 251():112440. PubMed ID: 38065049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, Structural, and Cytotoxic Properties of New Water-Soluble Copper(II) Complexes based on 2,9-Dimethyl-1,10-Phenanthroline and Their One Derivative Containing 1,3,5-Triaza-7-Phosphaadamantane-7-Oxide.
    Śliwa EI; Śliwińska-Hill U; Bażanów B; Siczek M; Kłak J; Smoleński P
    Molecules; 2020 Feb; 25(3):. PubMed ID: 32046362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Two new ternary complexes of copper(II) with tetracycline or doxycycline and 1,10-phenanthroline and their potential as antitumoral: cytotoxicity and DNA cleavage.
    Silva PP; Guerra W; Silveira JN; Ferreira AM; Bortolotto T; Fischer FL; Terenzi H; Neves A; Pereira-Maia EC
    Inorg Chem; 2011 Jul; 50(14):6414-24. PubMed ID: 21692452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer, antibacterial and antifungal activity of new ni (ii) and cu (ii) complexes of imidazole-phenanthroline derivatives.
    Moghadam ME; Divsalar A; Zare MS; Gholizadeh R; Mahalleh D; Saghatforosh L; Sanati S
    Nucleosides Nucleotides Nucleic Acids; 2017 Nov; 36(11):667-675. PubMed ID: 29185856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, X-ray crystal structure, DNA/BSA binding, DNA cleavage and cytotoxicity studies of phenanthroline based copper(II)/zinc(II) complexes.
    Wang Q; Mao H; Wang W; Zhu H; Dai L; Chen Y; Tang X
    Biometals; 2017 Aug; 30(4):575-587. PubMed ID: 28616784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mixed-1,10-phenanthroline-Cu(II) complexes: synthesis, cytotoxic activity versus hematological and solid tumor cells and complex formation equilibria with glutathione.
    Pivetta T; Isaia F; Verani G; Cannas C; Serra L; Castellano C; Demartin F; Pilla F; Manca M; Pani A
    J Inorg Biochem; 2012 Sep; 114():28-37. PubMed ID: 22687563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. May iron(III) complexes containing phenanthroline derivatives as ligands be prospective anticancer agents?
    Matos CP; Adiguzel Z; Yildizhan Y; Cevatemre B; Onder TB; Cevik O; Nunes P; Ferreira LP; Carvalho MD; Campos DL; Pavan FR; Pessoa JC; Garcia MH; Tomaz AI; Correia I; Acilan C
    Eur J Med Chem; 2019 Aug; 176():492-512. PubMed ID: 31132480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mixed-ligand mononuclear copper(II) complex: crystal structure and anticancer activity.
    Qin XY; Liu YN; Yu QQ; Yang LC; Liu Y; Zhou YH; Liu J
    ChemMedChem; 2014 Aug; 9(8):1665-71. PubMed ID: 24839939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Syntheses and crystal structures of tetracopper(II) complexes bridged by asymmetric N,N'-bis(substituted)oxamides: Molecular docking, DNA-binding and in vitro anticancer activity.
    Li XJ; Zheng K; Wang LD; Li YT; Wu ZY; Yan CW
    J Inorg Biochem; 2013 Nov; 128():97-107. PubMed ID: 23948578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis, X-ray crystal structures and biomimetic and anticancer activities of novel copper(II)benzoate complexes incorporating 2-(4'-thiazolyl)benzimidazole (thiabendazole), 2-(2-pyridyl)benzimidazole and 1,10-phenanthroline as chelating nitrogen donor ligands.
    Devereux M; O Shea D; Kellett A; McCann M; Walsh M; Egan D; Deegan C; Kedziora K; Rosair G; Müller-Bunz H
    J Inorg Biochem; 2007 Jun; 101(6):881-92. PubMed ID: 17397929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mixed copper(ii)-phenanthroline complexes induce cell death of ovarian cancer cells by evoking the unfolded protein response.
    Moráň L; Pivetta T; Masuri S; Vašíčková K; Walter F; Prehn J; Elkalaf M; Trnka J; Havel J; Vaňhara P
    Metallomics; 2019 Sep; 11(9):1481-1489. PubMed ID: 31348483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure of new tetracopper(II) complexes bridged by 2-{N'-[2-(dimethylamino)ethyl]oxamido}benzoate: DNA-binding and anticancer activity.
    Zheng YJ; Li XW; Li YT; Wu ZY; Yan CW
    J Photochem Photobiol B; 2012 Sep; 114():27-37. PubMed ID: 22704662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
    Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
    J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mixed ligand copper(II) complexes of N,N-bis(benzimidazol-2-ylmethyl)amine (BBA) with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Riyasdeen A; Akbarsha MA; Palaniandavar M
    Inorg Chem; 2012 May; 51(10):5512-32. PubMed ID: 22559171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper(II) Complexes of Phenanthroline and Histidine Containing Ligands: Synthesis, Characterization and Evaluation of their DNA Cleavage and Cytotoxic Activity.
    Leite SM; Lima LM; Gama S; Mendes F; Orio M; Bento I; Paulo A; Delgado R; Iranzo O
    Inorg Chem; 2016 Nov; 55(22):11801-11814. PubMed ID: 27934321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.